VOLUME
61 2000 NUMBER 12
Brainstorms
894 New Drug Discovery in the Postgenomic Era: From Genomics
to Proteomics. Stephen M. Stahl
[PDF]
Original Articles
896 Citalopram Therapy for Depression: A Review of 10 Years of
European Experience and Data From U.S. Clinical Trials. Martin
B. Keller
[Abstract]
[PDF]
909 Safety and Tolerability of a Rapidly Escalating
Dose-Loading Regimen for Risperidone. David Feifel, Christine
Y. Moutier, and William Perry
[Abstract]
[PDF]
912 Switching Clozapine Responders to Olanzapine. Kimberly
H. Littrell, Craig G. Johnson, Nicole M. Hilligoss, Carol D.
Peabody, and Steven H. Littrell
[Abstract]
[PDF]
916 Divalproex Sodium in Substance Abusers With Mood Disorder.
Mark J. Albanese, Reynolds C. Clodfelter, and Edward J.
Khantzian
[Abstract]
[PDF]
922 Sertraline Treatment of Panic Disorder: Response in
Patients at Risk for Poor Outcome. Mark H. Pollack, Mark H.
Rapaport, Cathryn M. Clary, Jack Mardekian, and Robert Wolkow
[Abstract]
[PDF]
928 Patient Compliance to a New Enteric-Coated Weekly
Formulation of Fluoxetine During Continuation Treatment of Major
Depressive Disorder. Ami Claxton, Erik de Klerk, Mark Parry,
James M. Robinson, and Mark E. Schmidt
[Abstract]
[PDF]
933 Intramuscular Ziprasidone Compared With Intramuscular
Haloperidol in the Treatment of Acute Psychosis. Shlomo Brook,
James V. Lucey, and Kevin P. Gunn, for the Ziprasidone I.M. Study
Group
[Abstract]
[PDF]
942 Efficacy and Response Time to Sertraline Versus Fluoxetine
in the Treatment of Unipolar Major Depressive Disorder. Rita
A. Suri, Lori L. Altshuler, Natasha L. Rasgon, Jeffrey L.
Calcagno, Mark A. Frye, Michael J. Gitlin, Sun Hwang, and Joni
Zuckerbrow-Miller
[Abstract]
[PDF]
Academic Highlights
955 The Scourge of EPS: Have Atypical Antipsychotics Solved
the Problem?
[PDF]
CME Article 963
964 Heterogeneity of Response to Antipsychotics From Multiple
Disorders in the Schizophrenia Spectrum. David L. Garver,
Jennifer A. Holcomb, and James D. Christensen
[Abstract]
[PDF]
Letters to the Editor
947 Divalproex Sodium for Alcohol Withdrawal and Relapse
Prevention: A Case Report. Lance P. Longo
[PDF]
948 The Effectiveness of Combining Lithium With Olanzapine in
the Treatment of Resistant Schizophrenia. Joaquin C. Martin,
Gines Palenciano, and Rocio Perez
[PDF]
949 Treatment of Primary Cranial Dystonia (Meige's Syndrome)
With Clozapine. Angelika Sieche and Henner Giedke
[PDF]
949 Severe Lithium Toxicity Induced by Combined Levofloxacin
Administration. Hitoshi Takahashi, Hisashi Higuchi, and Tetsuo
Shimizu
[PDF]
950 Colon Perforation and Peritonitis Associated With
Clozapine. Oliver Freudenreich and Donald C. Goff
[PDF]
951 Treatment of Koro With Citalopram. Jaime E. C. Hallak,
Jose A. S. Crippa, and Antonio Waldo Zuardi
[PDF]
Book Reviews 952
Subject Index 975
Author Index 986
Information for Authors
see July 2000, pages 542-544 or our Web site at www.psychiatrist.com/author.htm
|